The Federal Trade Commission has also stepped in to bar questionable stem cell companies from marketing their unproven treatments. "There might be a limited number of regulatory options that ...

and the top stem cell companies are working hard to make advancements that can help patients. Stem cells serve as an internal repair system in the body. They can divide without limit to replenish ...

So far, the Patent and Trademark Office has awarded only one iPS-related patent, granted to San Diego stem cell company Fate Therapeutics, and the patent is fairly limited in scope (Nat.